BNP/CALL/ROCHE GS/255/0.1/20.12.24 Share Price

Warrant

DE000PC21RX1

Real-time Boerse Frankfurt Warrants 07:51:03 01/07/2024 pm IST
1.21 EUR 0.00% Intraday chart for BNP/CALL/ROCHE GS/255/0.1/20.12.24
Current month+98.36%
1 month+105.08%
Date Price Change
01/24/01 1.21 0.00%
28/24/28 1.21 -4.72%
27/24/27 1.27 +3.25%
26/24/26 1.23 -12.14%
25/24/25 1.4 -9.09%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 07:51 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC21RX
ISINDE000PC21RX1
Date issued 05/01/2024
Strike 255 CHF
Maturity 20/12/2024 (172 Days)
Parity 10 : 1
Emission price 1.13
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.78
Lowest since issue 0.3
Delta0.49x
Omega 10.43
Premium6.54x
Gearing21.25x
Moneyness 0.9820
Difference Strike 4.65 CHF
Difference Strike %+1.82%
Spread 0.01
Spread %0.82%
Theoretical value 1.235
Implied Volatility 19.34 %
Total Loss Probability 55.97 %
Intrinsic value 0.000000
Present value 1.235
Break even 266.98 €
Theta-0.03x
Vega0.07x
Rho0.05x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus